FDA approves Wegovy to lower risk for CVD events in patients with obesity
Mar 08, 2024
Agency’s action could widen access to the drug if more insurance companies decide to cover it
Four JAK inhibitors have comparable efficacy, safety for RA
Dec 01, 2023
Baseline CRP, Clinical Disease Activity Index and glucocorticoid dose predict resistance to CDAI-low disease activity achievement.
Reduced vancomycin susceptibility tied to poorer C. diff outcomes
Apr 30, 2024
Poorer outcomes were seen for 30-day sustained clinical response and 14-day initial cure rates.
Insulin out-of-pocket cost caps do not increase insulin use
Mar 26, 2024
Caps are associated with a reduction in insulin costs, mainly driven by patients enrolled in health savings accounts.
Prescription opioids linked to increased risk for serious fall events
Feb 20, 2024
The findings seen among adults of all ages, especially those aged 85 years or older; the risk was highest in the first 28 days after initiation.
New AI app uses ‘selfies’ to generate health diagnostics
By
Aaron Dorman
Jun 26, 2023
The Together app is the first program to use “generative AI” to record a variety of symptoms including blood pressure, heart rate and blood oxygen, according to Renee, the company that introduced it...
Tirzepatide improves 24-hour BP in obesity-related hypertension
Feb 07, 2024
A reduction was noted in 24-hour systolic BP at 36 weeks with treatment at 5, 10 15 mg tirzepatide versus placebo.
AHA: Semaglutide cuts risk for CVD events in patients without diabetes
Nov 14, 2023
Findings seen over three years in adults with preexisting cardiovascular disease and overweight or obesity
Risk profile IDs COVID-19 patients who will benefit from baricitinib
Feb 26, 2024
Baricitinib plus remdesivir was linked to a reduced risk of death and progression to invasive mechanical ventilation.
Being in good shape tied to fewer mental health Rx
Sep 11, 2023
There was not an association noted between a reduced risk for medication use for adults aged 65 or more years.